jarun011 Arbutus Biopharma Corporation (NASDAQ:ABUS) is a clinical-stage biopharmaceutical company focused on developing chronic hepatitis B [cHBV] therapies. ABUS’ strategy[...]
Alexandros Michailidis In the last few years, I covered several pharmaceutical companies – including Gilead Sciences, Inc. (GILD), Novo Nordisk[...]
LaylaBird Since my last article, Pfizer’s share price (NYSE:NYSE:PFE) has risen by over 10%, and I believe the bull run[...]
aprott Shares of GLP-1 concern Structure Therapeutics Inc. (NASDAQ:GPCR) rallied over 50% after updated data suggests that its GSBR-1290 can[...]
BlackJack3D The following segment was excerpted from this fund letter. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) We first purchased shares of[...]